In over 10 years of research, anti-CCD IgE reactions emerged as being clinically irrelevant. Positive results based on CCDs therefore must be rated as false-positives. The confusing results thus obtained, especially with multi-allergen test systems, can easily be corrected by the use of the ProGlycAn CCD-inhibitor.